Background Maternal rectovaginal colonization with group B Streptococcus (GBS) is the
most common pathway for GBS disease in mother, fetus, and newborn. This article, the …

Invasive disease due to group B Streptococcus infection (Streptococcus agalactiae) results
in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are …

Neonatal sepsis is associated with severe morbidity and mortality in the neonatal period.
Clinical manifestations range from subclinical infection to severe local or systemic infection …

Group B Streptococcus (GBS) colonizes the gastrointestinal and vaginal epithelium of a
significant percentage of healthy women, with potential for ascending intrauterine infection …

Background Colonization and transmission precede invasive group B streptococcal (GBS)
disease. Data on GBS colonization prevalence, detection methods and risk factors for …

Background In many parts of the world, Group B Streptococcus (GBS) is a major cause of
maternal and neonatal illness and mortality. It has a negative impact on neonatal and …

Background Little is known of the burden of Group B Streptococcus (GBS) colonization
among pregnant women in Jordan. We conducted a pilot study to determine the prevalence …

Background. Streptococcus agalactiae (group B Streptococcus, GBS) is one of the causes of
maternal and neonatal morbidity and mortality in many parts of the world. It is associated …

Abstract Background Streptococcus agalactiae or Group B Streptococcus (GBS) is the
leading cause of neonatal morbidity and mortality resulting in septicaemia, bacteraemia and …

Background The main purpose of this study was to investigate the prevalence rate,
antimicrobial susceptibility patterns and molecular characteristics of Streptococcus …